  |
| Investors / Financing History |
| Oxford
BioMedica was established in 1995 as a spin-out from Oxford
University.
To date, the Company has raised a total of £117 million (US$189
million) to fund its research and clinical programmes.
The IPO on the Alternative Investment Market of the London Stock Exchange in December 1996 raised £5.1 million. A further £6 million was raised by a rights issue and placing in March/April 1998, £3.6 million by a rights issue in March 1999, £5.2 million in a Placing in January 2000 and £8.8 million in a Placing in August 2000. Oxford BioMedica’s move to the official list of the London Stock Exchange was completed in April 2001 along with a £35.5 million fund raising, before costs, from a placing and open offer. A Rights Issue for £22.1 million, before costs, was completed in October 2003. A further share offering in December 2005 raised £30.1 million before expenses, including an investment of £2.9 million by Sigma-Aldrich.
Website by College Hill - Life Sciences |
